CDKL3 and esophageal adenocarcinoma: Although bioinformatics analysis was conducted in ESCA patients including ESCC and esophageal adenocarcinoma, the vitro study evidence only confirmed the role of CDKL3 in ESCC cell lines while lacking data in esophageal adenocarcinoma.